• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Venezuela Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Venezuela Pharmaceuticals and Healthcare Report Q1 2013

  • ID: 2424669
  • February 2013
  • Region: Venezuela
  • 143 pages
  • Business Monitor International

BMI View

High inflation, currency devaluation, import and foreign currency controls, as well as other structurally distorting policies in Venezuela have made the country's pharmaceutical market increasingly unattractive to multinationals. We expect the market to grow below nominal GDP levels between 2011 and 2015, and experience a contraction in real growth terms.

Headline Expenditure Projections

- Pharmaceuticals: VEB36.28bn (US$8.45bn) in 2011 to VEB44.85bn (US$10.44bn) in 2012; +23.6% in local currency terms and +23.6% in US dollar terms. Forecasts up due to new macroeconomic information.

- Healthcare: VEB64.07bn (US$14.92bn) in 2011 to VEB81.68bn (US$19.02bn) in 2012; +27.5% in local currency terms and +27.5% in US dollar terms. Forecasts up due to new macro data.

- Medical devices: VEB11.07bn (US$2.58bn) in 2011 to VEB14.11bn (US$3.29bn) in 2012; +27.5% in local currency terms and 27.5% in US dollar terms. Forecasts up due to new macroeconomic data.

BMI Industry View 7

SWOT 9

Political 11

Economic 12

Business Environment 13

Industry Forecast 14

Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, 2009-2017 15

Healthcare Market Forecast 16
Table: Overall Healthcare Expenditure, 2009-2017 17
Table: Government Healthcare Expenditure, 2009-2017 17
Table: Private Healthcare Expenditure, 2009-2017 18
Table: VENEZUELA - ECONOMIC ACTIVITY 24

Prescription Drug Market Forecast 24
Table: Prescription Drug Sales, 2009-2017 25

Patented Drug Market Forecast 26
Table: Patented Drug Sales, 2009-2017 27

Generic Drug Market Forecast 28
Table: Generic Drug Sales, 2009-2017 29

OTC Drug Market Forecast 30
Table: OTC Medicine Sales, 2009-2017 31

Industry Forecast Import/Export 32
Table: Pharmaceutical Trade, 2009-2017 34
Table: Pharmaceutical Trade, 2008-2016 34

Medical Devices Forecast 35
Table: Table: Medical Device Sales, 2009-2017 36

Industry Forecast Other Healthcare Data 36

Key Risks To BMI's Forecast Scenario 37

Industry Risk Reward Ratings 39
Table: Table: Americas Pharmaceutical Risk/Reward Ratings, Q113 39

Market Overview 42

Industry Trends And Developments 43

Epidemiology 43

Communicable Diseases 43

Non-Communicable Diseases 44

Healthcare Sector Developments 46

Hospital Sector 51

Private Healthcare Sector 59

Supply Chain 63
Table: Members of CAVEDRO, 2009 64

Research & Development 66

Medical Devices 67

Regulatory Development 69

Regulatory Regime 69

Intellectual Property 70

Regulatory Developments 72

Pharmaceutical Registration 73
Table: Registration Requirements 74
Table: Renewal Requirements 76

Advertising 77

Biologics And Biosimilars 78

Intellectual Property Issues 78

International Collaboration 81

Pricing 82

Reimbursement 87

Competitive Landscape 88

Pharmaceutical Sector 88

Foreign Industry 89

Domestic Industry 91
Table: Members of CAMESIP, 2010 93

Pharmaceutical Distribution 93
Table: Members of CAVEFAR, 2009 95

Production 98
Table: Members of CAVEME, 2010 99
Table: Members of CIFAR, 2010 100

Company Developments 101

Company Profile 110

Grupo Farma 110

Elmor 113

Strides Latina (Sumifarma) 116

Calox International 118

Pfizer 120

Sanofi 124

GlaxoSmithKline 126

Boehringer Ingelheim 129

Novartis 131

Merck & Co 133

Demographic Forecast 135

Venezuela Demographic Data 135
Table: Venezuela's Population By Age Group, 1990-2020 ('000) 136
Table: Venezuela's Population By Age Group, 1990-2020 (% of total) 137
Table: Venezuela's Key Population Ratios, 1990-2020 138
Table: Venezuela's Rural And Urban Population, 1990-2020 138

Glossary 139

Methodology 141

Methodology 141

Risk/Reward Ratings Methodology 141

Ratings Overview 142
Table: Pharmaceutical Business Environment Indicators 142

Weighting 143
Table: Weighting Of Components 143

Sources 143

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos